MRSA_sequencing_as_infection_control
Evaluating the impact of routine whole genome sequencing of methicillin-resistant Staphylococcus aureus (MRSA) on hospital infection prevention and control decisions. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/